• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 215/16 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 215/16

Total number of patents in this class: 82

10-year publication summary

7
10
3
3
4
6
4
2
3
1
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Merck Sharp & Dohme Corp.
2183
3
The Johns Hopkins University
5887
3
Agc, Inc.
5537
3
Boehringer Ingelheim International GmbH
4493
2
Massachusetts Institute of Technology
10254
2
Astellas Pharma Inc.
1043
2
Hetero Research Foundation
172
2
Flagship Pioneering Innovations V, Inc.
220
2
Ancureall Pharmaceutical (Shanghai) Co., Ltd.
11
2
The Regents of the University of California
20778
1
Janssen Pharmaceutica N.V.
3162
1
Wyeth LLC
605
1
Syngenta Participations AG
1516
1
Bayer AG
3499
1
The Regents of the University of Michigan
4997
1
President and Fellows of Harvard College
6092
1
Abbvie Inc.
1824
1
Vertex Pharmaceuticals (europe) Limited
18
1
University of Southern California
2134
1
Duke University
3182
1
Other owners 50